Presented By: Center for the Discovery of New Medicines - CDNM
Drug Discovery Seminar: “For Scientists By Scientists: Case Studies in Eli Lilly’s Open Innovation Drug Discovery Platform”
Julia Clay, Ph.D.
The Lilly Open Innovation Drug Discovery (OIDD) Program is founded on the belief that pharmaceutical companies, research institutions and academia share a mutual desire to advance innovative biomedical science. OIDD is a premier collaborative platform that unites global investigators with Lilly scientists to both uncover and create innovation that may positively impact the people we serve.
Explore Similar Events
-
Loading Similar Events...